UROPH- 1411207-AA SEP2022
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
The Rezūm System is intended to relieve symptoms, obstructions, and reduce prostate tissue associated with BPH. It is indicated for men ≥ 50 years of age with a prostate volume 30cm3 ≤ 80cm3. The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe.
All images are the property of Boston Scientific.
All trademarks are the property of their respective owners.